Sanjiv Patel

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Soo-Yeun Lim, as attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Sanjiv Patel

Form 4 holding President and CEO, Director

Relay Therapeutics, Inc.

Security class
Common Stock
Shares / value
199,548
Estimated value
$3,733,543
Report date
17 Aug 2026
Price
$18.71
Ownership
By The Patel Family Irrevocable Trust of 2019
Form 4 holding President and CEO, Director

Relay Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
1,450,000
Estimated value
Report date
13 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

PROTHENA CORP PUBLIC LTD CO

Security class
Stock Option (Right to Buy)
Shares / value
15,000
Estimated value
Report date
18 May 2022
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Sanjiv Patel

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .